James (Jim) Adox - Profile and Investment Details

Investor Profile

James (Jim) Adox is a Venture Capital, Private Equity Firm based in Ann Arbor, Michigan, United States with a diverse investment portfolio that includes companies such as Elucent Medical, UpTo, Virent Energy Systems, EnsoData, Invenra, Celleration, Inviragen, IntraLase Corporation, Zystor, Third Wave Technologies, Chromatin, Thalchemy, Madison Vaccines, Alfalight, Nextt, InterSymbol Communications, NeuWave Medical, HealthMyne, Pattern Insight, TomoTherapy, FluGen, BlueWillow Biologics, Roche NimbleGen, Mithridion, Silatronix, NeuMoDx Molecular, Corona Optical Systems, ReShape Lifesciences, Prevacept Infection Control, NERITES, Juventas Therapeutics, Promega, Neurovance, SoftSwitching Technologies, Health Scholars, SkySpecs, Delphinus Medical Technologies, Deltanoid Pharmaceuticals, TAI Diagnostics, ProCertus BioPharm, HistoSonics, Aerpio Pharmaceuticals, Eximis Surgical, Tissue Regeneration Systems, LensX Lasers, Incept, Cellectar Biosciences, Gala Biotech, Euthymics Bioscience, Netsocket, Akebia Therapeutics. Over time, James (Jim) Adox has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether James (Jim) Adox is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Asset Management, Women Founded, Medical Testing, Life Science, Artificial Intelligence (AI), Robotics, Information Technology (IT), Biotech, Analytics, Medical Device, Software, Healthcare, Biotechnology, Energy Efficiency, Hispanic / Latinx Founded, Health IT, Aerospace, Wind Energy, Hispanic / Latinx Led, Health Diagnostics, Drones, Renewable Energy, Medical, Therapeutics, Media and Entertainment, Machine Learning, Pharmaceuticals, Productivity Tools may find it worthwhile to explore potential connections with James (Jim) Adox, as their portfolio suggests a familiarity and interest in this area.

Understanding James (Jim) Adox’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.